Therapies for Clinically Localized Prostate Cancer Update

AHRQ has released an update of a 2008 research review on Therapies for Clinically Localized Prostate Cancer.

According to the review, more evidence is needed to evaluate comparative risks and benefits of therapies. Similar findings in the 2008 review found that no single therapy can be considered the preferred treatment for localized prostate cancer because of limitations in the body of evidence as well as the likely tradeoffs a patient must make between estimated treatment effectiveness, necessity, and adverse effects.

Select to access the full report and executive summary of Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review.

Page last reviewed January 2015
Internet Citation: Therapies for Clinically Localized Prostate Cancer Update. January 2015. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/ehc-newreview.html